todays selling is meaningless. The recent news was excellent and established a framework from which to rebuild the company. Yes, it will take time but the company should do well once ponatinib is marketed again.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.